meds2u limited

Live EstablishedSmallDeclining

meds2u limited Company Information

Share MEDS2U LIMITED

Company Number

09071415

Shareholders

duaa healthcare ltd

Group Structure

View All

Industry

Other human health activities

 

Registered Address

1st floor, portfolio place, 498 broadway, oldham, OL9 9PY

Website

-

meds2u limited Estimated Valuation

£1.2m

Pomanda estimates the enterprise value of MEDS2U LIMITED at £1.2m based on a Turnover of £2.1m and 0.55x industry multiple (adjusted for size and gross margin).

meds2u limited Estimated Valuation

£0

Pomanda estimates the enterprise value of MEDS2U LIMITED at £0 based on an EBITDA of £-667.4k and a 4.04x industry multiple (adjusted for size and gross margin).

meds2u limited Estimated Valuation

£2.5k

Pomanda estimates the enterprise value of MEDS2U LIMITED at £2.5k based on Net Assets of £1k and 2.46x industry multiple (adjusted for liquidity).

Edit your figures and get a professional valuation report.

Meds2u Limited Overview

Meds2u Limited is a live company located in oldham, OL9 9PY with a Companies House number of 09071415. It operates in the other human health activities sector, SIC Code 86900. Founded in June 2014, it's largest shareholder is duaa healthcare ltd with a 100% stake. Meds2u Limited is a established, small sized company, Pomanda has estimated its turnover at £2.1m with declining growth in recent years.

View Sample
View Sample
View Sample

Upgrade for unlimited company reports & a free credit check

Meds2u Limited Health Check

Pomanda's financial health check has awarded Meds2U Limited a 3 rating. We use a traffic light system to show it exceeds the industry average on 3 measures and has 6 areas for improvement. Company Health Check FAQs

Health Check Image
Health Rating3out of 5
positive_score

3 Strong

positive_score

3 Regular

positive_score

6 Weak

size

Size

annual sales of £2.1m, make it larger than the average company (£671.2k)

£2.1m - Meds2u Limited

£671.2k - Industry AVG

growth

Growth

3 year (CAGR) sales growth of -13%, show it is growing at a slower rate (5.5%)

-13% - Meds2u Limited

5.5% - Industry AVG

production

Production

with a gross margin of 38.2%, this company has a comparable cost of product (38.2%)

38.2% - Meds2u Limited

38.2% - Industry AVG

profitability

Profitability

an operating margin of -32.1% make it less profitable than the average company (5.9%)

-32.1% - Meds2u Limited

5.9% - Industry AVG

employees

Employees

with 11 employees, this is below the industry average (17)

11 - Meds2u Limited

17 - Industry AVG

paystructure

Pay Structure

on an average salary of £25.8k, the company has an equivalent pay structure (£25.8k)

£25.8k - Meds2u Limited

£25.8k - Industry AVG

efficiency

Efficiency

resulting in sales per employee of £191.3k, this is more efficient (£48.1k)

£191.3k - Meds2u Limited

£48.1k - Industry AVG

debtordays

Debtor Days

it gets paid by customers after 54 days, this is later than average (24 days)

54 days - Meds2u Limited

24 days - Industry AVG

creditordays

Creditor Days

its suppliers are paid after 60 days, this is slower than average (19 days)

60 days - Meds2u Limited

19 days - Industry AVG

stockdays

Stock Days

it holds stock equivalent to 16 days, this is in line with average (13 days)

16 days - Meds2u Limited

13 days - Industry AVG

cashbalance

Cash Balance

has cash to cover current liabilities for 14 weeks, this is less cash available to meet short term requirements (111 weeks)

14 weeks - Meds2u Limited

111 weeks - Industry AVG

debtlevel

Debt Level

it has a ratio of liabilities to total assets of 99.8%, this is a higher level of debt than the average (26.7%)

99.8% - Meds2u Limited

26.7% - Industry AVG

MEDS2U LIMITED financials

EXPORTms excel logo

Meds2U Limited's latest turnover from April 2023 is estimated at £2.1 million and the company has net assets of £1 thousand. According to their latest financial statements, Meds2U Limited has 11 employees and maintains cash reserves of £173.6 thousand as reported in the balance sheet.

Data source: Companies HousePomanda Estimates

Apr 2023Jun 2022Jun 2021Jun 2020Jun 2019Jun 2018Jun 2017Jun 2016Jun 2015
Turnover2,103,8492,445,0263,309,7383,187,8475,424,8182,515,9362,866,6922,168,1446,689,563
Other Income Or Grants000000000
Cost Of Sales1,300,4291,530,2932,193,8092,035,8863,503,9651,619,9171,762,2671,354,1314,227,996
Gross Profit803,419914,7331,115,9301,151,9621,920,853896,0191,104,425814,0132,461,567
Admin Expenses1,479,071602,2091,020,0941,104,5501,836,976866,8551,088,501673,9922,367,475
Operating Profit-675,652312,52495,83647,41283,87729,16415,924140,02194,092
Interest Payable000000000
Interest Receivable9,1584,6044522657665241717912
Pre-Tax Profit-666,494317,12896,28847,67784,64329,68916,095140,10094,104
Tax0-60,254-18,295-9,059-16,082-5,641-3,058-28,020-18,821
Profit After Tax-666,494256,87477,99338,61868,56124,04813,037112,08075,283
Dividends Paid000000000
Retained Profit-666,494256,87477,99338,61868,56124,04813,037112,08075,283
Employee Costs284,278270,405260,662231,3392,937,9581,346,3801,533,063104,2413,733,122
Number Of Employees1111111012961715172
EBITDA*-667,431342,231131,12683,655204,938126,285106,187163,69894,092

* Earnings Before Interest, Tax, Depreciation and Amortisation

Apr 2023Jun 2022Jun 2021Jun 2020Jun 2019Jun 2018Jun 2017Jun 2016Jun 2015
Tangible Assets33,07175,221101,39199,779136,02257,85631,91018,3956,204
Intangible Assets00000083,777167,555188,499
Investments & Other000000000
Debtors (Due After 1 year)000000000
Total Fixed Assets33,07175,221101,39199,779136,02257,856115,687185,950194,703
Stock & work in progress57,867123,68063,68063,68060,630175,62525,62923,52123,521
Trade Debtors312,723325,729440,947457,774421,942165,939221,377298,110422,979
Group Debtors0658,6300000000
Misc Debtors30,77944,72230,28024,13944,88957,85167,35957,7820
Cash173,628257,355479,302424,728104,35299,877109,90626,6554,771
misc current assets000000000
total current assets574,9971,410,1161,014,209970,321631,813499,292424,271406,068451,271
total assets608,0681,485,3371,115,6001,070,100767,835557,148539,958592,018645,974
Bank overdraft000000000
Bank loan000000000
Trade Creditors 214,263275,015276,146275,394311,309204,484210,248295,758569,691
Group/Directors Accounts000000000
other short term finances000000000
hp & lease commitments013,52613,52613,52612,9430000
other current liabilities392,805518,419391,162403,20190,112127,216128,310107,8970
total current liabilities607,068806,960680,834692,121414,364331,700338,558403,655569,691
loans000000000
hp & lease commitments010,88324,14645,35200000
Accruals and Deferred Income000000000
other liabilities000059,4620000
provisions000000000
total long term liabilities010,88324,14645,35259,4620000
total liabilities607,068817,843704,980737,473473,826331,700338,558403,655569,691
net assets1,000667,494410,620332,627294,009225,448201,400188,36376,283
total shareholders funds1,000667,494410,620332,627294,009225,448201,400188,36376,283
Apr 2023Jun 2022Jun 2021Jun 2020Jun 2019Jun 2018Jun 2017Jun 2016Jun 2015
Operating Activities
Operating Profit-675,652312,52495,83647,41283,87729,16415,924140,02194,092
Depreciation8,22129,70735,29036,24331,67613,3446,4852,7330
Amortisation000089,38583,77783,77820,9440
Tax0-60,254-18,295-9,059-16,082-5,641-3,058-28,020-18,821
Stock-65,81360,00003,050-114,995149,9962,108023,521
Debtors-685,579557,854-10,68615,082243,041-64,946-67,156-67,087422,979
Creditors-60,752-1,131752-35,915106,825-5,764-85,510-273,933569,691
Accruals and Deferred Income-125,614127,257-12,039313,089-37,104-1,09420,413107,8970
Deferred Taxes & Provisions000000000
Cash flow from operations-102,405-209,751112,230333,638130,53128,736103,08036,729198,462
Investing Activities
capital expenditure33,929-3,537-36,9020-199,227-39,290-20,000-14,924-194,703
Change in Investments000000000
cash flow from investments33,929-3,537-36,9020-199,227-39,290-20,000-14,924-194,703
Financing Activities
Bank loans000000000
Group/Directors Accounts000000000
Other Short Term Loans 000000000
Long term loans000000000
Hire Purchase and Lease Commitments-24,409-13,263-21,20645,93512,9430000
other long term liabilities000-59,46259,4620000
share issue000000001,000
interest9,1584,6044522657665241717912
cash flow from financing-15,251-8,659-20,754-13,26273,171524171791,012
cash and cash equivalents
cash-83,727-221,94754,574320,3764,475-10,02983,25121,8844,771
overdraft000000000
change in cash-83,727-221,94754,574320,3764,475-10,02983,25121,8844,771

meds2u limited Credit Report and Business Information

Very Low Risk70 - 100
Low Risk50 - 70
Moderate Risk30 - 50
High Risk20 - 30
Very High Risk0 - 20
Get a comprehensive credit check for meds2u limited. Get real-time insights into meds2u limited's credit score, group structure and payment trends.

From as little as £6.99

This will not impact your credit rating!

View Credit Report Sample

Meds2u Limited Competitor Analysis

competitor_analysis_table_img

Perform a competitor analysis for meds2u limited by selecting its closest rivals, whether from the HUMAN HEALTH AND SOCIAL WORK ACTIVITIES sector, other small companies, companies in OL9 area or any other competitors across 12 key performance metrics.

meds2u limited Ownership

MEDS2U LIMITED group structure

Meds2U Limited has no subsidiary companies.

Ultimate parent company

MEDS2U LIMITED

09071415

MEDS2U LIMITED Shareholders

duaa healthcare ltd 100%

meds2u limited directors

Meds2U Limited currently has 3 directors. The longest serving directors include Mr Mohammed Balal (May 2023) and Mr Ghulam Mahmood (May 2023).

officercountryagestartendrole
Mr Mohammed BalalEngland33 years May 2023- Director
Mr Ghulam MahmoodEngland32 years May 2023- Director
Mr Ijaz AhmedEngland52 years May 2023- Director

P&L

April 2023

turnover

2.1m

-14%

operating profit

-675.7k

0%

gross margin

38.2%

+2.07%

turnover

Turnover, or revenue, is the amount of sales generated by a company within the financial year.

Balance Sheet

April 2023

net assets

1k

-1%

total assets

608.1k

-0.59%

cash

173.6k

-0.33%

net assets

Total assets minus all liabilities

meds2u limited company details

company number

09071415

Type

Private limited with Share Capital

industry

86900 - Other human health activities

incorporation date

June 2014

age

11

incorporated

UK

ultimate parent company

None

accounts

Total Exemption Full

last accounts submitted

April 2023

previous names

N/A

accountant

-

auditor

-

address

1st floor, portfolio place, 498 broadway, oldham, OL9 9PY

Bank

-

Legal Advisor

-

meds2u limited Charges & Mortgages

A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.

We found 4 charges/mortgages relating to meds2u limited. Currently there are 2 open charges and 2 have been satisfied in the past.

meds2u limited Capital Raised & Share Issues BETA

When a company issues new shares, e.g. to new investors following a funding round, it is required to notify Companies House within one month of making an allotment of shares.

Click to start generating capital raising & share issue transactions for MEDS2U LIMITED. This can take several minutes, an email will notify you when this has completed.

meds2u limited Companies House Filings - See Documents

datedescriptionview/download